{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:21:42Z","timestamp":1787815302650,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.09.103","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T07:52:49Z","timestamp":1570780369000},"page":"39-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prevalence of human papillomavirus (HPV)-vaccine types by race\/ethnicity and sociodemographic factors in women with high-grade cervical intraepithelial neoplasia (CIN2\/3\/AIS), Alameda County, California, United States"],"prefix":"10.1016","volume":"38","author":[{"given":"Kayla","family":"Saadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia W.","family":"Gargano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Whitney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy D.","family":"Querec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.09.103_b0005","unstructured":"U.S. Cancer Statistics Working Group. U.S. Cancer Statistics Data Visualizations Tool, based on November 2018 submission data (1999-2016): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2019. www.cdc.gov\/cancer\/dataviz [accessed 5 August 2019]."},{"key":"10.1016\/j.vaccine.2019.09.103_b0010","doi-asserted-by":"crossref","first-page":"djv086","DOI":"10.1093\/jnci\/djv086","article-title":"US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines","volume":"107","author":"Saraiya","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2019.09.103_b0015","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1086\/520654","article-title":"Quadrivalent Human Papillomavirus vaccine","volume":"45","author":"Gellin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.09.103_b0020","first-page":"909","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years \u2013 United States, 2017","volume":"67","author":"Walker","year":"2018","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2019.09.103_b0025","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/cncr.29266","article-title":"Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States","volume":"121","author":"Hariri","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2019.09.103_b0030","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jamaoncol.2016.3609","article-title":"Population-based incidence rates of cervical intraepithelial neoplasia in the human papillomavirus vaccine era","volume":"3","author":"Benard","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.vaccine.2019.09.103_b0035","first-page":"337","article-title":"Estimated number of cases of high-grade cervical lesions diagnosed among women \u2013 United States, 2008 and 2016","volume":"68","author":"McClung","year":"2019","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2019.09.103_b0040","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1158\/1055-9965.EPI-11-1019","article-title":"Costs associated with management of cervical human papillomavirus-related conditions","volume":"21","author":"Kruzikas","year":"2012","journal-title":"Cancer Epidemiol, Biomarkers Prev"},{"key":"10.1016\/j.vaccine.2019.09.103_b0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00404-013-2955-0","article-title":"Pregnancy outcome following loop electrosurgical excision procedure (LEEP) a systematic review and meta-analysis","volume":"289","author":"Jin","year":"2014","journal-title":"Arc Gynecol Obstet"},{"key":"10.1016\/j.vaccine.2019.09.103_b0050","article-title":"Anxiety and distress following receipt of results from routine HPV primary testing in cervical screening: the psychological impact of primary screening (PIPS) study","author":"McBride","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2019.09.103_b0055","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/cid\/ciy707","article-title":"Trends in high-grade cervical lesions and cervical cancer screening in five states, 2008\u20132015","volume":"68","author":"Gargano","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.09.103_b0060","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1158\/1055-9965.EPI-18-0885","article-title":"Trends in human papillomavirus vaccine types 16 and 18 in cervical precancers, 2008\u20132014","volume":"28","author":"McClung","year":"2019","journal-title":"Cancer Epidemiol, Biomarkers Prev"},{"key":"10.1016\/j.vaccine.2019.09.103_b0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amepre.2018.03.015","article-title":"Trends in high-grade cervical cancer precursors in the Human Papillomavirus vaccine era","volume":"55","author":"Oakley","year":"2018","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2019.09.103_b0070","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/OLQ.0000000000000492","article-title":"Prevalence of 9-valent human papillomavirus types by race\/ethnicity in the prevaccine era, United States, 2003\u20132006","volume":"43","author":"Liu","year":"2016","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2019.09.103_b0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1158\/1055-9965.EPI-14-0649","article-title":"HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in population-based evaluation in the United States","volume":"24","author":"Hariri","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.vaccine.2019.09.103_b0080","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/infdis\/jis627","article-title":"Human Papillomavirus genotypes in high-grade cervical lesions in the United States","volume":"206","author":"Hariri","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.09.103_b0085","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1002\/cncr.28038","article-title":"Individual and geographic disparities in human papillomavirus types 16\/18 in high-grade cervical lesions","volume":"119","author":"Niccolai","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2019.09.103_b0090","unstructured":"Alameda County Public Health Department. Healthy Alameda County: 2019 demographics. Oakland, CA; 2019. http:\/\/www.healthyalamedacounty.org\/demographicdata. [accessed 17 September 2018]."},{"key":"10.1016\/j.vaccine.2019.09.103_b0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/aje\/kwi188","article-title":"Easy SAS calculations for risk or prevalence ratios and differences","volume":"162","author":"Spiegelman","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2019.09.103_b0100","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2019.09.103_b0105","unstructured":"Jang S. Racial and ethnic variation in the incidence of cervical pre-cancer in Alameda County, California, 2008-2015 [abstract]. In: American Public Health Association\u2019s 2018 Annual Meeting and Expo. 2018 Nov 10-14; San Diego, CA. https:\/\/apha.confex.com\/apha\/2018\/meetingapp.cgi\/Paper\/399217. [accessed 4 September 2019]."},{"key":"10.1016\/j.vaccine.2019.09.103_b0110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.amepre.2017.08.017","article-title":"HPV vaccination among foreign-born women: examining the National Health Interview Survey 2013\u20132015","volume":"54","author":"Cofie","year":"2018","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2019.09.103_b0115","first-page":"1","article-title":"Surveillance of vaccination coverage among adult populations \u2013 United States, 2015","volume":"66","author":"Williams","year":"2017","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2019.09.103_b0120","unstructured":"Alameda County Public Health Department. Immigration and Public Health: An Issue Brief. 2017. http:\/\/www.acphd.org\/media\/470384\/immigration.pdf. [accessed 28 August 2019]."},{"key":"10.1016\/j.vaccine.2019.09.103_b0125","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/LGT.0000000000000422","article-title":"Cervical cancer screening among women by birthplace and percent of lifetime living in the United States","volume":"4","author":"Endshaw","year":"2018","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.vaccine.2019.09.103_b0130","doi-asserted-by":"crossref","first-page":"e79260","DOI":"10.1371\/journal.pone.0079260","article-title":"Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study","volume":"8","author":"Jaisamrarn","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.09.103_b0135","article-title":"Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease","volume":"38","author":"Serrano","year":"2012","journal-title":"Infect Agent Cancer"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:50:19Z","timestamp":1759402219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19313477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19313477"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.103","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of human papillomavirus (HPV)-vaccine types by race\/ethnicity and sociodemographic factors in women with high-grade cervical intraepithelial neoplasia (CIN2\/3\/AIS), Alameda County, California, United States","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}